tradingkey.logo
tradingkey.logo

Immunitybio Announces Approval In Macau SAR, China For Anktiva

ReutersMar 20, 2026 5:33 PM

- Immunitybio Inc IBRX.O:

  • IMMUNITYBIO ANNOUNCES APPROVAL IN MACAU SAR, CHINA FOR ANKTIVA® IN BCG-UNRESPONSIVE NMIBC WITH CIS ± PAPILLARY TUMORS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI